In Brief
Refine Search
Pharmaceutical
UK-based immunotherapy firm Centauri Therapeutics has secured a £1 million ($1.25 million) grant from PACE (Pathways to Antimicrobial Clinical Efficacy) to further develop its Alphamer technology. 25 November 2024
Biotechnology
Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per share in cash. 23 November 2024
Biotechnology
Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and RefinedScience. The value was not disclosed, but this extension follows a $30 million Series A fundraiser in March 2023. 22 November 2024
Biotechnology
Sweden-based BioArctic saw its fall 7.5% to 139.90 kronor on Friday, after its announced that its partner, Japan’s Eisa, has updated its revenue outlook for the Alzheimer’s treatment Leqembi (lecanemab) for the 2024 fiscal year (FY), which runs from April 2024 through March 2025. 11 November 2024
Biotechnology
Danish biotech Gubra announces that Germany’s Boehringer Ingelheim has decided to discontinue the development of the long-acting neuropeptide Y receptor type 2 (NPY2R) agonist BI 1820237 in obesity. 4 November 2024
Biotechnology
Japanese drugmaker Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (US brand name Leqembi) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA. 1 November 2024
Pharmaceutical
GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. 25 October 2024
Pharmaceutical
Following a re-examination, the European Medicines Agency’s human health committee, CHMP confirmed its initial recommendation to refuse the granting of a conditional marketing authorization for Masitinib AB Science’s masitinib. 18 October 2024
Pharmaceutical
University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments. 17 October 2024
Pharmaceutical
Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. 15 October 2024
Pharmaceutical
French pharma major Sanofi revealed it has entered into negotiations with private equity firm Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in Opella, its consumer healthcare business. 14 October 2024
Pharmaceutical
The UK’s new 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) came into force at the beginning of January this year. 4 October 2024
Biotechnology
Sirnaomics, a firm specializing in RNAi therapeutics, has entered into a subscription agreement with biotech specialist Poon Hung Fai. 4 October 2024
Biotechnology
GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS). 4 October 2024
Biotechnology
Oxford, UK-based Enara Bio today announces the closing of a $32.5 million Series B financing supported by a strong syndicate of new and existing biotech investors. 3 October 2024
Pharmaceutical
French drugmaker Mitem Pharmavhas the worldwide acquisition of Desferal (deferoxamine), a major MITM in hematology, from Swiss giant Novartis. 25 September 2024
article
The European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has elected Bruno Sepodes as its new chair. 19 September 2024
Pharmaceutical
The Austrian Academy of Sciences (OeAW) is further expanding its focus on life sciences by opening an institute for biomedical artificial intelligence (AI) based on a 150 million euros ($166.8 million) funding from the German non-profit Boehringer Ingelheim Foundation (BIS). 18 September 2024
Biotechnology
Zenas BioPharma announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. 13 September 2024
Biotechnology
Having been collaborating for a decade, US RNA-targeted drug developer Ionis Pharmaceuticals and Swiss pharm giant Roche have signed a new agreement. 28 September 2023
Biotechnology
Shares of US biotech Gritstone bio leapt almost 31% to $1.57 in pre-market trading on the news it had been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA). 28 September 2023
Biotechnology
Seattle, USA-based clinical-stage biopharma Avalyn Pharmaceuticals has announced the closing of an oversubscribed $175 million Series C financing. 28 September 2023
Biotechnology
Sweden-based AAX Biotech revealed that Maria Lisa Knudsen has been appointed as chief executive of the company. 28 September 2023
Pharmaceutical
Ophthalmic company Ocuphire Pharma, a specialist in retinal and refractive eye disorders, together with partner Viatris, have secured US approval for Ryzumvi (phentolamine). 27 September 2023
Biotechnology
CRISPR genome-editing biopharma company Caribou Biosciences (Nasdaq: CRBU) dipped 3% to $4.76, after it revealed it has received notice from a unit of AbbVie (NYSE: ABBV) revealing that the US pharma major has elected to terminate the collaboration and license agreement, first signed in February 2021. 27 September 2023
Biotechnology
Gilead Sciences has released a statement confirming it has stopped its ENHANCE-2 study of magrolimab in acute myeloid leukemia (AML). 27 September 2023
Biotechnology
The US Food and Drug Administration has granted a new approval for US pharma giant Pfizer’s hematologic malignancies drug Bosulif (bosutinib). 27 September 2023
Biotechnology
Adding to recent big-bucks deals with Merck & Co and Boehringer Ingelheim, Ginkgo Bioworks has now signed a collaboration deal with US pharma giant Pfizer focused on the discovery of RNA-based drug candidates. 27 September 2023
Pharmaceutical
US biopharma Soleno Therapeutics saw its market capitalization leap five-fold yesterday, with the shares hitting $26.80, after it announced promising research results for its lead pipeline candidate, which has encountered previous setbacks. 27 September 2023
Generics
A report from industry analyst GlobalData finds that a range of new generic products in idiopathic pulmonary fibrosis (IPF) will likely shake up the market in coming years. 27 September 2023
Biotechnology
Italy-based Alfasigma has reached an agreement to acquire US biopharma Intercept Pharmaceuticals. 27 September 2023
Biotechnology
UK clinical-stage biotech PureTech Health today announced the appointment of Robert Lyne as chief portfolio officer. 27 September 2023
Biotechnology
Swedish biotech Biosergen saw its shares close down 14.4% at 1.37 kronor yesterday after it revealed a co-development and licensing deal with Indian drugmaker Alkem Laboratories for BSG005, an innovative polyene macrolide, through Phase II and phase III trials for sale in the Indian market. 27 September 2023
Pharmaceutical
USA-based Ionis Pharmaceuticals yesterday released positive top-line results for the Phase III Balance study of olezarsen in people with familial chylomicronemia syndrome (FCS), a rare genetic disorder. 27 September 2023
Generics
The inaugural report from the Access to Medicine Foundation's Generic and Biosimilar Medicines Program has taken a look at what five major industry players are doing to expand access to their products in low- and middle-income countries (LMICs). 26 September 2023
Biotechnology
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Coherus BioSciences’ application for Udenyca Onbody, the company's on-body injector (OBI) form of Udenyca (pegfilgrastim-cbqv). 26 September 2023
Biotechnology
Shares of Immunovant were up a massive 80% at $36.63 by mid-morning, after the Roivant Sciences company released data from an early study of an autoimmune disease drug. 26 September 2023
Generics
India's Department of Pharmaceuticals is seeking innovative technologies to reduce the cost of producing Active Pharmaceutical Ingredients (APIs) that are currently imported. 26 September 2023
Biotechnology
California, USA-based biotech AcuraStem has entered into a license agreement with Japan’s largest pharma company Takeda to develop and commercialize AcuraStem's PIKFYVE targeted therapeutics including AS-202, an innovative antisense oligonucleotide (ASO) for the treatment of amyotrophic lateral sclerosis (ALS). 26 September 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze